Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care [...]
The 150-year-old drugmaker is the first company in health care [...]
Eli Lilly’s latest high-profile crossovers—which include a starry TV partnership [...]
Hundreds of industry leaders have signed a letter to FDA [...]
Maryland is becoming the home away from home for British [...]
The approval came “months earlier than anticipated,” Pfizer’s Chief Oncology Officer, [...]
The FDA has opened an investigation into Takeda’s recombinant protein [...]
The FDA is hiring more than 1,000 new employees and [...]
Cosette had been attempting to invalidate its $430 million buyout [...]
Some four years into Jemperli’s commercial life span, a rift [...]
No matter who Fierce could pull aside for a quick [...]